Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,531.00 1.00 (0.07%)

Bid:

1,531.00

Ask:

1,532.00

Spread: 1.00 (0.065%)

Market Cap: £3.22b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Hikma Pharmaceuticals News

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, foll...

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while m...

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the ye...

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new a...

UK dividends calendar - next 7 days

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following ...

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquis...